Hypothalamic-pituitary-adrenal axis
From Free net encyclopedia
The hypothalamic-pituitary-adrenal axis (HPA axis) is a major part of the neuroendocrine system that controls reactions to stress and has important functions in regulating various body processes such as digestion, the immune system and energy usage. Species from humans to the most ancient organisms share components of the HPA axis. It is the mechanism for a set of interactions among glands, hormones and parts of the mid-brain that mediate a general adaptation syndrome.
Contents |
Anatomy
The key elements of the HPA axis are:
- The paraventricular nucleus of the hypothalamus, which contains neuroendocrine neurons that synthesise and secrete vasopressin and corticotropin-releasing factor (CRF). These two peptides regulate
- The anterior lobe of the pituitary gland. In particular, CRF and vasopressin stimulate the secretion of adrenocorticotropic hormone (ACTH). ACTH in turn acts on
- the adrenal cortices, which produces glucocorticoid hormones (mainly cortisol in humans)response to stimulation by ACTH. Glucocorticoids in turn act back at the hypothalamus and pituitary (negative feedback).
CRF and vasopressin are released from neurosecretory nerve terminals at the median eminence. They are transported to the anterior pituitary through the portal blood vessel system of the hypophyseal stalk. There, CRF and vasopressin act synergistically to stimulate the secretion of stored ACTH from corticotrope cells. ACTH is transported by the blood to the adrenal cortex of the adrenal gland, where it rapidly stimulates biosynthesis of corticosteroids from cholesterol. Cortisol has effects on many tissues in the body, including on the brain. In the brain, cortisol acts at two types of receptor - mineralocorticoid receptors and glucocorticoid receptors, and these are expressed by many different types of neuron. One important target of glucocorticoids is the hippocampus, which is a major controlling centre of the HPA axis.
Function
Release of CRF from the hypothalamus is influenced by stress, by blood levels of cortisol and by the sleep/wake cycle. In healthy individuals, cortisol rises rapidly after wakening, reaching a peak within 30-45 minutes. It then gradually reduces over the day, rising again in late afternoon. Cortisol levels then fall in late evening, reaching a trough during the middle of the night. An abnormally flattened circadian cortisol cycle has been linked with chronic fatigue syndrome (MacHale, 1998), insomnia (Backhaus, 2004) and burnout (Pruessner, 1999).
Anatomical connections between amygdala, hippocampus, and hypothalamus facilitate activation of the HPA axis. Sensory information arriving at the lateral aspect of the amygdala is processed and conveyed to the central nucleus, which projects to several parts of the brain involved in responses to fear. At the hypothalamus, fear-signaling impulses activate both the sympathetic nervous system and the modulating systems of the HPA axis.
Increased production of cortisol mediates alarm reactions to stress, facilitating an adaptive phase of a general adaptation syndrome in which alarm reactions are suppressed, allowing the body to attempt countermeasures.
Glucocorticoids have many important functions, including modulation of stress reactions but in excess they can be damaging. Atrophy of the hippocampus in humans and animals exposed to severe stress is believed to be caused by prolonged exposure to high concentrations of glucocorticoids. Deficiencies of the hippocampus may reduce the memory resources available to help a body formulate appropriate reactions to stress.
The HPA axis is involved in the neurobiology of mood disorders and functional illnesses, including anxiety disorder, bipolar disorder, post-traumatic stress disorder, clinical depression, burnout, chronic fatigue syndrome and irritable bowel syndrome.
Research
Experimental studies have investigated many different types of stress, and their effects on the HPA axis in many different circumstances. Stressors can be of many different types - in experimental studies in rats, a distinction is often made between "social stress" and "physical stress", but both types activate the HPA axis, though via different pathways. Several monoamine neurotransmitters are important in regulating the HPA axis, especially dopamine, serotonin and norepinephrine (noradrenaline).
The HPA axis is a feature of other vertebrates as well as of mammals. For example, biologists studying stress in fish showed that social subordination leads to chronic stress, related to reduced aggressive interactions, to lack of control and to the constant threat imposed by dominant fish. Serotonin (5HT) appeared to be the active neurotransmitter involved in mediating stress responses, and increases in serotonin are related to increased plasma α-MSH levels, which causes skin darkening (a social signal in salmonoid fish), activation of the HPA axis, and inhibition of aggression. Inclusion of the amino acid L-tryptophan, a precursor of 5HT, in the feed of rainbow trout made the trout less aggressive and less responsive to stress (PMID 11807104). However, the study mentions that plasma cortisol was not affected by dietary L-tryptophan.
See also
References
General
- "Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala" by Z. Merali et al. in J Neurosci volume 18(12), pages 4758-66 (1998).
Relation to illnesses
- "Sleep disturbances are correlated with decreased morning awakening salivary cortisol" by J. Backhaus et al. in Psychoneuroendocrinology volume 29(9), pages 1184-91 (2004).
- "Burnout, perceived stress, and cortisol responses to awakening" by J. C. Pruessner et al. in Psychosom Med volume 61(2), pages 197-204 (1999).
- "Diurnal variation of adrenocortical activity in chronic fatigue syndrome" by S. M. MacHale et al. in Neuropsychobiology volume 38(4), pages 213-7 (1998).
- "Actual stress, psychopathology and salivary cortisol levels in the irritable bowel syndrome (IBS)" by F. R. Patacchioli et al. in J Endocrinol Invest. volume 24(3), pages 173-7 (2001).